GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kwangdong Healthbio Co Ltd (XKRX:086220) » Definitions » Equity-to-Asset

Kwangdong Healthbio Co (XKRX:086220) Equity-to-Asset : 0.32 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Kwangdong Healthbio Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Kwangdong Healthbio Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩18,051 Mil. Kwangdong Healthbio Co's Total Assets for the quarter that ended in Dec. 2023 was ₩56,897 Mil. Therefore, Kwangdong Healthbio Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.32.

The historical rank and industry rank for Kwangdong Healthbio Co's Equity-to-Asset or its related term are showing as below:

XKRX:086220' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.27   Med: 0.31   Max: 0.57
Current: 0.32

During the past 10 years, the highest Equity to Asset Ratio of Kwangdong Healthbio Co was 0.57. The lowest was 0.27. And the median was 0.31.

XKRX:086220's Equity-to-Asset is ranked worse than
79.03% of 1927 companies
in the Consumer Packaged Goods industry
Industry Median: 0.54 vs XKRX:086220: 0.32

Kwangdong Healthbio Co Equity-to-Asset Historical Data

The historical data trend for Kwangdong Healthbio Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kwangdong Healthbio Co Equity-to-Asset Chart

Kwangdong Healthbio Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.27 0.28 0.32 0.32

Kwangdong Healthbio Co Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.27 0.28 0.32 0.32

Competitive Comparison of Kwangdong Healthbio Co's Equity-to-Asset

For the Household & Personal Products subindustry, Kwangdong Healthbio Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kwangdong Healthbio Co's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kwangdong Healthbio Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Kwangdong Healthbio Co's Equity-to-Asset falls into.



Kwangdong Healthbio Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Kwangdong Healthbio Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=18051.429/56897.42
=0.32

Kwangdong Healthbio Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=18051.429/56897.42
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kwangdong Healthbio Co  (XKRX:086220) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Kwangdong Healthbio Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Kwangdong Healthbio Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Kwangdong Healthbio Co (XKRX:086220) Business Description

Traded in Other Exchanges
N/A
Address
Bundang Suji U-Tower, 767 Sinsu-ro, 7th floor, Building A, Yongin-si, Gyeonggi-do, Suji-gu, KOR
BL Healthcare Corp is a Bio-venture company, which develops, manufactures, and sells health functional food and pharmaceutical products. The Company's products include weight-loss pills, vitamins, and other nutrition supplements. It also produces personal care items such as cosmetics, hair care products, and skincare products.

Kwangdong Healthbio Co (XKRX:086220) Headlines

No Headlines